Unilabs and C2N Diagnostics, LLC recently announced they inked a multi-year partnership agreement to increase access to the latter’s CE-marked Alzheimer’s tests in Europe, including Norway, Switzerland, and the United Kingdom. The agreement also will provide access to the tests in Peru, Saudi Arabia, and the United Arab Emirates.
“Alzheimer's disease is on the rise, making it essential to innovate by offering less invasive and more accessible diagnostic procedures...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?